First, LSF transcriptionally regulates osteoponin (OPN) in HCC, which activates c-Met signaling, thereby mediating the oncogenic function of LSF and promoting metastasis [5, 6]. The gene discussed is TFCP2; the disease is hepatocellular carcinoma.